MedTrace Logo

Aveir DR Real-World Evidence Post-Approval Study

NCT05935007 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1805

Last updated 2026-05-20

No results posted yet for this study

Summary

The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.

Conditions

  • Cardiac Pacemaker
  • Arrythmia
  • Bradycardia

Interventions

DEVICE

Aveir DR Leadless Pacemaker System

This study will utilize real-world data from patients implanted with the Aveir DR Leadless Pacemaker System. No device intervention will be conducted in this study.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Nicole Harbert · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05935007 on ClinicalTrials.gov